This registration page may not work well in Internet Explorer. Please use a different browser to complete your registration.

Recorded Webinar Featuring Joyce Bischoff

December 7, 2023 12:00 AM - December 8, 2024 12:00 AM (EST)

Description

Join us for a webinar with Joyce Bischoff, Ph.D., Professor of Surgery at Harvard Medical School/Boston Children's Hospital. She will present her talk entitled: “Cellular Drivers and Drug Mechanisms in Infantile Hemangioma."  

Abstract:   Infantile hemangioma (IH) is a benign vascular tumor that occurs in 5% of infants; in ~10% of cases, the vascular overgrowth causes severe problems for the infant.    Propranolol was discovered serendipitously to be effective for IH; despite its success, there is significant need for improved therapies because of side effects caused by its non-selective β-blocker activity.  We previously showed the R+ enantiomer of propranolol, which lacks β-blocker activity, inhibits hemangioma stem cell (HemSC) vessel formation in vivo and HemSC to endothelial differentiation in vitro via disruption of the transcription factor SOX18 - indicating a β-adrenergic independent mechanism for propranolol therapy in IH (Seebauer et al., JCI 2022).

In new experiments, we discovered R+ propranolol suppresses the mevalonate pathway in HemSC undergoing endothelial differentiation. The mevalonate pathway, central to cholesterol biosynthesis, is controlled by the rate-limiting enzyme 3 hydroxy-3-methylglutaryl-coenzyme A reductase. Confirming its functional requirement, simvastatin and atorvastatin inhibited HemSC vessel formation in vivo and HemSC endothelial differentiation in vitro. R+ propranolol inhibited maturation of SREBP-2, the master transcription factor for the mevalonate pathway genes and further, R+ propranolol reduced endogenous cholesterol levels in human ECs.  Sm4, a SOX18 inhibitor, showed similar results in these experiments.   

We propose an entirely novel SOX18-mevalonate pathway axis as a central regulatory process in IH-vascular overgrowth. This presents potentially new clinical research directions in which R+ propranolol and/or statins could be tested for efficacy in IH and other vascular anomalies in which SOX18 is expressed.  

 


Time

This recording is available 24/7 from now through 1 year anniversary of webinar. 


Contact Information

North American Vascular Biology Organization
Name: Bernadette Englert
Phone: (301) 760-7745
Email: bernadette@navbo.org
We're sorry. No registrations are currently available. You may wish to contact the event organizer for assistance.
{{ vm.EventInfo.ErrorMessage }}

Select Registration Options

Edit
{{vm.regWarningMessage}}
{{vm.regAlertMessage}}

Exhibitor Opportunities

Name Price Att Qty
{{ et.Name }}
{{ et.IncludedAttendeesCount }} {{ et.AttendeeRegType.RemainingPerType }} Remaining {{ et.AttendeeRegType.RemainingPerType * -1 }} on Waiting List {{ et.AttendeeRegType.RemainingPerType * -1 }} Over Limit
{{ et.Remaining }} Remaining
Sold out

Attendee Registration Options Total Remaining: {{ vm.EventInfo.VacantSpotsPerEvent }}

Waiting List Available
{{ vm.stats.totalAttendeesCount }} Registered , {{ vm.OverallOverAmount() }} on Waiting List , {{ vm.OverallOverAmount() }} Over Limit
Name Price Qty
{{ rt.Name }}
{{ rt.IsMemberOnly ? ' (Members Only)' : '' }}
Limit: {{ rt.LimitPerPurchase }}
Included Attendees: {{ rt.AttendeesCountPerOneRegistration }}
{{rt.Price | currency }} {{rt.PriceAfterDiscount | currency }} {{ rt.Price | currency }}
{{ rt.RemainingPerType }} Remaining
{{ rt.RemainingPerType * -1 }} on Waiting List
{{ rt.RemainingPerType * -1 }} Over Limit

{{'[[Sponsorship]] Opportunities' | localizeString:'['}}

Name Price Att Qty
{{ st.Name }}
{{ st.IncludedAttendeesCount }} {{ st.AttendeeRegType.RemainingPerType }} Remaining {{ st.AttendeeRegType.RemainingPerType * -1 }} on Waiting List {{ st.AttendeeRegType.RemainingPerType * -1 }} Over Limit
{{ st.Remaining }} Remaining
Sold out
Continue

Registration Information

Edit

Exhibitor - {{er.Name}}

Exhibitor #{{ $index + 1 }}

Total: {{exhibitor.TotalPrice | currency}} {{ exhibitor.IsBenefit ? "- Included as a Benefit" : exhibitor.IsDiscounted ? "- Discounts have been applied" : ""}}
Exhibitor Directory
Primary Contact
Booth Information
Additional Information
Additional Items

Attendee - {{er.Name}}

{{ att.getAttendeeTerm(vm.EventSettings.AdditionalAttendeesTerm, $index) }} #{{ att.getAttendeeIndexDisplay(vm.EventSettings.AdditionalAttendeesTerm, $index) }}

Total: {{att.TotalPrice | currency}} {{att.DiscountMessage | localizeString:'['}}
A No Show fee is being assessed for {{fee.EventName}} on {{fee.EventStartLocalTimeString}}.

Address


Phone

Additional Information
Event Sessions

{{slot.Name}}

{{$select.selected.SessionName}}
(full)
{{slot.SelectedSession.SessionDescription + (slot.HasFees ? " (Price: " + (slot.PriceTotal | currency) +")" : "")}}

Additional Items

{{'[[Sponsorship+]]' | localizeString:'['}} - {{er.Name}}

{{'[[Sponsor]]' | localizeString:'['}} #{{ $index + 1 }}

Total: {{sponsor.Price | currency}}
Continue

Additional Items

Edit

{{(vm.EventInfo.Terms.Donation || "Fundraising") + " Opportunities"}}

Campaign Name Item Description Amount
{{item.CampaignName}} {{item.Description + (item.ShowMinimumPrice && item.MinimumPrice ? " (Min: " + item.MinimumPrice + ")" : "")}}
Continue

Complete Registration

Edit

Terms & Conditions

No Show Policy

{{ vm.EventInfo.EventSettings.NoShowPolicy }}

Enter Promo Code

This event is synced to a webinar so no confirmation email will be sent from GrowthZone.

Thank you to our {{'[[Sponsor+]]' | localizeString:'['}}